Finally, we could assume that p-bromo compound 3 is the one that combines the most versatile action, since it is active in all three cancer cell lines and can inhibit membrane PD-L1 by half in MCF-7, showing inhibition rates of around 20% for the rest of the cell lines and on both targets. Here, CD274 is linked to cancer.